Disease/Infection News

RSS

Increased COVID-19 cases in US counties are attributed to meatpacking plants

An estimated 334,000 COVID-19 cases are attributable to meatpacking plants, resulting in $11.2 billion in economic damage, according to a new study led by a researcher at the University of California, Davis. The study was published in the journal Food Policy.

16 Apr 2021

Intestinal worm infection can cause severe sexually transmitted viral diseases

Infection with parasitic intestinal worms (helminths) can apparently cause sexually transmitted viral in-fections to be much more severe elsewhere in the body.

16 Apr 2021

Child vaccination rates decreased dramatically during COVID-19 pandemic, shows study

The numbers of recommended vaccine doses, including measles vaccine, administered to children decreased dramatically after the declaration of a national state of emergency on March 13, 2020, due to the COVID-19 pandemic, according to a Kaiser Permanente study published in Pediatrics.

16 Apr 2021

CRISIS survey offers better insights into the psychological and physical impact of COVID-19

To better understand the psychological and physical impact caused by the profound consequences of the COVID-19 pandemic - and also inform priorities for interventions and policy changes to address the mental health consequences of the pandemic.

16 Apr 2021

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Two MIT professors have proposed a new approach to estimating the risks of exposure to Covid-19 under different indoor settings.

16 Apr 2021

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

A UCLA Fielding School of Public Health-led team has found that Hispanic, Black, and Native Americans have carried the burden of the pandemic, both in overall mortality and specifically in years of potential life lost, in an analysis of 45 U.S. states and the District of Columbia (D.C.).

16 Apr 2021

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

This suggests a cocktail of antibodies will work better at neutralizing the virus than a single antibody alone. In a study published in the bioRxiv* preprint server, researchers report the structure of binding complexes of the different classes of antibodies to the spike RBD using computational modeling, which may also help explain how the virus generates escape mutations.

16 Apr 2021

Study: Norovirus clusters are resistant to detergent and ultraviolet disinfection

Clusters of a virus known to cause stomach flu are resistant to detergent and ultraviolet disinfection, according to new research co-led by Danmeng Shuai, Ph.D., an associate professor of civil and environmental engineering at the George Washington University and Nihal Altan-Bonnet, Ph.D., a senior investigator and the head of the Laboratory of Host-Pathogen Dynamics at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

COVID-19 pandemic limits access to opioid dependency treatment, increases overdose deaths

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

16 Apr 2021

New model for making accurate short-term projections of COVID-19 cases

A new study by Texas A&M University researchers published in PLOS ONE details a new model for making short-term projections of daily COVID-19 cases that is accurate, reliable and easily used by public health officials and other organizations.

16 Apr 2021

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka and the United Kingdom have found that more than 90% of vaccinated individuals produced an adequate amount of antibodies after receiving only one dose of the vaccine – irrespective of their age and gender.

16 Apr 2021

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

A past COVID-19 infection does not completely protect against reinfection in young people, according to an observational study of more than 3,000 healthy members of the US Marines Corps most of whom were aged 18-20 years, published in The Lancet Respiratory Medicine journal.

16 Apr 2021

Disease/Infection News

Increased COVID-19 cases in US counties are attributed to meatpacking plants

Intestinal worm infection can cause severe sexually transmitted viral diseases

Child vaccination rates decreased dramatically during COVID-19 pandemic, shows study

CRISIS survey offers better insights into the psychological and physical impact of COVID-19

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Analysis: Hispanic, Black, and Native Americans have carried the burden of COVID-19 pandemic

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

Study: Norovirus clusters are resistant to detergent and ultraviolet disinfection

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

COVID-19 pandemic limits access to opioid dependency treatment, increases overdose deaths

New model for making accurate short-term projections of COVID-19 cases

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

Epigenetic endowment of every person has an impact on COVID-19 severity

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

Obese or overweight patients at high risk for having worse COVID-19 outcomes

COVID-19 pandemic has worsened global maternal and perinatal outcomes

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News